CorMedix (CRMD) Revenue Growth (5y) (2018 - 2025)
CorMedix (CRMD) Revenue Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | CorMedix | 4.95 Mn | -150.25 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 370.61% |
| Sep 30, 2025 | 307.31% |
| Jun 30, 2025 | 374.94% |
| Mar 31, 2025 | 250.34% |
| Dec 31, 2024 | 316.91% |
| Sep 30, 2024 | 186.33% |
| Jun 30, 2024 | 86.99% |
| Dec 31, 2022 | -20.33% |
| Sep 30, 2022 | -35.50% |
| Jun 30, 2022 | -31.03% |
| Mar 31, 2022 | -28.03% |
| Dec 31, 2021 | 241.74% |
| Sep 30, 2021 | -3.04% |
| Jun 30, 2021 | -13.08% |
| Mar 31, 2021 | 16.33% |
| Dec 31, 2020 | 375.17% |
| Sep 30, 2020 | 381.34% |
| Jun 30, 2020 | 167.52% |
| Mar 31, 2020 | 373.85% |
| Dec 31, 2019 | -21.83% |